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Abstract 
PURPOSE: The purpose of this study was to evaluate the effectiveness of an education session to 
promote adherence to the United States Preventive Services Task Force (USPSTF) recommendation and 
Clinical Practice Guidelines for Treating Tobacco Use and Dependence by providers.   
METHODS:  A retrospective and prospective record review was used to evaluate an education session for 
providers in tobacco use screening, providing cessation counseling, prescribing medication for tobacco 
cessation and sending out referrals for tobacco cessation at one primary care clinic in Louisville, KY.  
Education sessions were held from August 1, 2018 to August 14, 2018. The sample consisted of 200 
randomly selected patient medical records from among current tobacco users. The retrospective study 
included 100 chart reviews from January 1, 2018 to March 31, 2018 and the prospective chart review 
included 100 chart reviews from August 15, 2018 to September 15, 2018.  
RESULTS: The group demographics did not differ significantly, demonstrating similarities among 
variables. There was no change in the rate of documentation of tobacco use screened by the providers 
during the pre- and post-intervention phases (31.3% vs. 31.3%). There were no statistically significant 
differences in documentation of tobacco use screening rates when comparing provider types. Both the 
pre- and post-intervention groups did not statistically differ with regard to the percentage of smoking 
cessation medications being prescribed. 
CONCLUSION: This project demonstrated a need for improvement in provider documentation in 
adherence with USPSTF recommendation and Treating Tobacco Use and Dependence Guidelines. In 
addition, there is a need for more thorough documentation of tobacco screening among known tobacco 
users in the primary care clinic. Further research is needed, using a larger study sample, to identify a 
continuous trend on screening rates. 
 
Keywords: Tobacco cessation, primary care, providers, education, recommendation, guidelines   
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The Effect of a Provider Education Program on Tobacco Use in an Adult Population in the Primary Care 
Setting 
Introduction 
Tobacco use is one of the most preventable causes of morbidity and mortality in the United 
States, yet it continues to be a serious primary health care issue (U.S Department of Health and Human 
Services [DHHS], 2014). According to the World Health Organization (WHO), more than 1.1 billion 
people smoked tobacco in 2015 (WHO, 2017). The consequences of tobacco use affect everyone in the 
community, not only the people who smoke. Consequences of not routinely screening for tobacco use and 
counseling tobacco users in cessation, include an increased risk of lung, heart, and vascular diseases 
(DHHS, 2014). In the United States, twenty percent of all deaths are caused by cigarette smoking 
(American Cancer Society [ACS], 2017).  Tobacco users have a decreased life expectancy compared to 
non-tobacco users. There are approximately 480,000 premature deaths annually and more than 300 billion 
dollars are spent in healthcare expenditures each year in the United States from disease related to tobacco 
use (Jamal et al., 2015). Hence, tobacco use could be considered the deadliest and costliest public health 
threat to our nation.  
The fight for tobacco cessation is crucial considering its severe health consequences. Tobacco use 
in any form, i.e. smoking, chewing or secondhand exposure, causes serious health issues. Smoking 
tobacco causes cardiovascular disease, lung cancer, and other lung diseases, such as chronic obstructive 
pulmonary disease (COPD) and asthma (DHHS, 2014). Secondhand smoke exposure can also cause 
asthma, birth defects, sudden infant death syndrome, chronic ear infections in kids, and frequent lung 
infections (Centers for Disease Control and Prevention [CDC], 2017). Because of the high risk of disease 
from tobacco use and exposure, reducing cigarette smoking by adults, 18 years and older, to 12 % is one 
of the objectives for Healthy People 2020 (Office of Disease Prevention and Health Promotion [ODPHP], 
2014).  
In 2016, the rate of cigarette smoking in the U.S was 15.5% (Odani et al., 2018); with a higher 
smoking prevalence among males compared to females, 17.5% and 13.5 %, respectively (Jamal et al., 
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2018). Unfortunately, Kentucky has one of the highest rates of cigarette smoking in the U.S., with 21.1% 
of adult Kentuckians currently smoking cigarettes, and 26.2% using any form of tobacco (Odani et al., 
2018). Based on these statistics it is of critical importance to address tobacco use.  The purpose of this 
study was to evaluate the effectiveness of an education session to promote provider adherence to the 
United States Preventive Services Task Force (USPSTF, 2015) recommendation and Clinical Practice 
Guidelines for Treating Tobacco Use and Dependence (Fiore, Jaen, Baker, et al., 2008). 
Background 
Nicotine from smoking is a very addictive substance, both physically and mentally, causing 
tobacco cessation to be increasingly difficult (Chaney & Sheriff, 2012). Tobacco use and its dependence 
is a chronic disease that often leads to several attempts to quit (Fiore et al., 2008). Patients who stop 
smoking may require multiple treatment approaches from their primary care provider (PCP) because of 
the risk of withdrawal symptoms and relapse (CDC, 2017).  “Although, 68% of the adult population 
who smoke indicate a desire to quit, only 55% make an attempt in the past year, and only 7.4% 
have recent success (Babb, 2017).  This finding suggests that there is a high proportion of individuals 
who want to quit tobacco and it is crucial for the PCP to assess and help these patients quit successfully. 
Thus, PCPs are in a key position to screen for tobacco use and engage their patient population in tobacco 
cessation treatments. 
By screening for tobacco use, the PCP can work with patients to help them to understand the 
chronicity of the disease process and provide evidence-based interventions to assist them in cessation. 
The United States Preventive Services Task Force (USPSTF) recommends asking the patient about 
tobacco use and subsequently providing tobacco cessation interventions by counseling, pharmacotherapy 
and implementing strategies for tobacco cessation (USPSTF, 2015). The PCP can influence significant 
outcomes in tobacco cessation programs by encouraging patients through motivational interviewing 
strategies and evidenced-based treatment interventions to successfully quit tobacco use (DHHS, 2014).   
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The Clinical Practice Guidelines for Treating Tobacco Use and Dependence: 2008 were 
generated from systematic reviews of the best available scientific literature and is recommended by the 
USPSTF to be used to identify the most appropriate pharmacotherapy and counseling options for the 
screened patient (Fiore et al., 2008). Evidence suggests that combining both counseling (motivational 
interviewing strategies, telephone quit-line) and medication for tobacco cessation are most effective to 
assist smokers in cessation (Fiore et al., 2008). Nicotine replacement therapy (NRT) for tobacco cessation 
has been shown to be more successful than a placebo or no treatment at all (Fiore et al., 2008). The non-
nicotinic based medications, like varenicline and bupropion, are also suggested by the clinical practice 
guidelines for successful quitting. Along with medication, behavioral counseling is very important for 
successful quitting. When behavioral counseling therapy is initiated, tobacco users are four times more 
likely to quit (Chaney & Sheriff, 2012). 
The “Five-A” model of brief intervention is an evidence-based tobacco cessation strategy that 
includes asking if the patient uses tobacco, advising the patient to quit, assessing for willingness to quit, 
assisting to quit and arranging for follow-up and support (Fiore et al., 2008). When PCPs are consistent in 
providing tobacco cessation interventions and discussing the harmful effects of continuous tobacco use at 
each visit, there is often a decrease in tobacco use as compared with no education provided (Laniado-
Laborin, 2010). One study found that one out of four patients will get the opportunity for tobacco 
cessation interventions in an outpatient visit (Jamal, Dube, & King 2015). By the combination of the 5-A 
model of brief intervention, education and evidence-based recommendation, the primary care provider 
can make a positive impact on tobacco cessation. 
Purpose 
The purpose of this study was to evaluate the effectiveness of an education program for providers 
to promote adherence to the USPSTF recommendation and Clinical Practice Guidelines for Treating 
Tobacco Use and Dependence at a primary care clinic in Louisville, Kentucky.  The study objectives were 
to identify the percentage rate of documentation for tobacco use at a primary care clinic between January 
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1, 2018 and March 31, 2018 and to use this pre-intervention data to compare with the post-intervention 
period of August 15, 2018 through September 15, 2018. The specific objectives that were focused on 
prior to and after implementation of the education session were: 
1. Identify the percentage rate of documentation of screening for tobacco use by the PCP. 
2. Identify the percentage rate of documentation of counseling, prescribing of tobacco 
cessation medications. 
3. Identify the referral rates of smoking cessation. 
Methods 
This was a single center, quasi-experimental, pre and post-intervention study. This study included 
both retrospective and prospective features. The study consisted of three phases: Pre-intervention phase, 
intervention phase, and post-intervention phase. The pre-intervention phase consisted of a retrospective 
review of data performed on 100 randomly selected patient charts who were current smokers and were 
seen from January 1, 2018, through March 31, 2018. The intervention phase took place between August 
1, 2018 through August 14, 2018 and consisted of educating all providers at the chosen clinic about the 
USPSTF recommendation and Treating Tobacco Use Dependence Guidelines and how to document this 
in the electronic medical record (EMR). The post-intervention phase consisted of a prospective review of 
data from 100 randomly selected patient charts who were current smokers and were seen from August 15, 
2018 through September 15, 2018. 
Setting 
The primary care clinic chosen for this study is located in Louisville, Kentucky.  Approximately 
2,200 patients are seen every month. The clinic is open five days a week and provides care by 
appointment only to adult patients, ages 18 and older. There are five physicians and five nurse 
practitioners who practice in this office and focus on management of acute and chronic diseases and 
preventive care. Two providers were excluded from the study because they either did not practice at this 
location during the pre-intervention phase so there would not be comparative data available or they did 
not attend the education session provided.  
EFFECT OF PROVIDER EDUCATION PROGRAM ON TOBACCO USE 
6 
 
Sample 
The sample consisted of medical records of 100 randomly selected patients for the pre-
intervention phase and 100 randomly selected patients for the post-intervention phase. Both pre-
intervention and post-intervention data were compared. Inclusion criteria consisted of adult patients who 
were 18 years and older at the time of the visit, active cigarette smokers, patients who were seen by the 
eight providers who consented to the study, and patients who were charged based on the following 
Current Procedural Terminology (CPT) codes for new, established and preventive visits(99202, 99203, 
99204, 99205, 99212, 99213, 99214, 99215, 99385, 99386, 99387, 99395, 99396, 99397). The exclusion 
criteria consisted of any patients who admitted to using smokeless tobacco (chewing tobacco and vaping) 
and any patients who were seen by the other two providers in the office. The following variables were 
collected in both the pre and post intervention chart reviews: Age, gender, race, type of visit (annual, 
episodic, or follow-up), type of health insurance, type of provider (physician or nurse practitioner), and 
CPT codes used. Documentation of tobacco screening, patient education, medication prescription and 
referral were also reviewed.  
The Intervention 
All providers from the primary care clinic were asked to attend one of ten face-to-face 
educational sessions that were available from August 1, 2018 through August 14, 2018.  During the 
session the project was explained to providers and those who consented were asked at that time to 
voluntarily sign an informed consent. Providers included in the study were four physicians and four nurse 
practitioners. Education consisted of detailed information on tobacco cessation based on materials from 
the USPSTF recommendation and Treating Tobacco Use and Dependence Guidelines. A printed 
educational handout for tobacco cessation and correct EMR documentation was created (Refer to 
Appendix A). A tip sheet for how to add the referral for smoking cessation in the EMR was provided, 
along with CPT codes to use for reimbursement by commercial insurance and Medicare for tobacco 
use/abuse (Refer to Appendix A). 
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Data collection 
 Approvals from the University of Kentucky Institutional Review Board (IRB) and the 
Norton Healthcare Office of Research and Administration (NHORA) were obtained prior to the collection 
of data. After the intervention period, a random sample of patient charts were obtained from NHORA 
through the Norton Healthcare electronic patient database. During data collection, patient records were 
accessed using the patient medical record number (MRN), data were abstracted based on the list below, 
and then transferred to an electronic spreadsheet.  The demographic variables obtained from the charts 
included age, gender, race, type of visit (annual, episodic, or follow-up), type of health insurance, type of 
provider (physician or nurse practitioner), and CPT codes used. Each patient’s chart was assessed for 
tobacco use screening by looking at the provider’s documentation in the “History of Present Illness” 
(HPI) section of the chart. If screening was performed it was coded as ‘1’ for Yes and if screening was 
not performed it was coded as ‘2’ for No. Education on smoking cessation by providers was also 
assessed. Data for this measure were obtained from the “Tobacco Screening and Education Section” of 
the EMR. Charts with a documentation of education provided were coded as ‘1’ and those without were 
coded as ‘2’. Another measure that was evaluated was whether a Federal Drug Administration (FDA) 
approved medication for smoking cessation was prescribed. The data for this measure were obtained from 
the “Plan” section of the EMR. FDA approved medications for smoking cessation include the nicotine 
patch, gum, lozenge, inhaler, or nasal spray, varenicline, and bupropion. Charts with a documentation of 
any of these medications prescribed were coded as ‘1’ and those without were coded as ‘2’. A list of 
specific medications prescribed was also obtained. The last measure assessed for documentation in the 
EMR was if a referral to smoking cessation resources was initiated. Data for this measure were obtained 
from the “Referral” section of the chart. This measure was based on the documentation of referral to any 
tobacco treatment program, such as the USPSTFs telephone quit line or the American Lung Association’s 
Freedom from Smoking classes. Charts with a documentation of any referrals initiated were coded as ‘1’ 
and those without were coded as ‘2’.  
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Data Analysis 
 Data were analyzed using SPSS statistics software (Version 23.0). Descriptive statistics, 
including frequency distributions and percentages were used to summarize the demographic variables 
data for the pre and post intervention of the patient demographics. The Chi-Square Test of Association 
was used to evaluate for significance of association between variables. All data analysis was conducted 
using Microsoft Excel. 
Results 
Sample Characteristics 
A total of 200 patient charts were reviewed. The pre-intervention sample consisted of charts from 
100 randomly selected patients and 100 randomly selected patients for the post-intervention sample. Only 
96 charts met the inclusion criteria in the pre-intervention phase. The four charts excluded from the study 
were due to patients having a status as a former smoker, smokeless tobacco user, and deceased. Similarly, 
in the post-intervention phase 99 charts met the inclusion criteria. The excluded chart was due to status as 
a smokeless tobacco user. Almost half of the samples in each phase were between the ages of 41-60 and 
about a quarter were in the other age groups. The majority of patients were female (57.3%) and Caucasian 
(80.2%), followed by African American and Hispanic (11.5%, 5.2% respectively). The pre-intervention 
and post-intervention demographic characteristics as to age group, gender, race/ethnicity, type of health 
insurance, type of visit, and type of provider are presented in Table 1. The group demographics did not 
differ significantly, demonstrating similarities. There were not statistically significant differences in group 
demographics between the pre-intervention and post-intervention groups.  
Documentation of Screening 
There was no change in the rate of documentation of tobacco use screening by the providers 
during the pre-intervention (31.3%)  and post-intervention phases (31.3%) p=0.992. There were no 
statistically significant differences in documentation of tobacco use screening rates when comparing 
provider types. The pre-intervention sample demonstrated a higher number of patients who were screened 
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by nurse practitioners (59.4%) as opposed to the post-intervention sample who was screened more 
frequently by physicians (52.5%). Episodic visits were shown to be the most frequent type of visit during 
both phases, but documentation of tobacco screening was the lowest during these encounters. Annual 
visits were actually the least frequent type of visit encountered but had the highest adherence rate in 
documentation of tobacco screening.   
Counseling, Medications, and Referrals 
  Documentation of counseling by the providers did not differ between the pre-interventions and 
post-intervention samples (26.0% vs. 31.3%, p=0.416). As a whole, both the pre-intervention (10.4%) and 
post-intervention (12.1%) groups did not statistically differ  with regard to the percentage of smoking 
cessation medications being prescribed (p=0.707)  Figure 2 illustrates the comparison between both 
groups and medications prescribed. There was no difference between the pre-intervention (n=1) and post-
intervention (n=0) groups with regard to referrals being sent to tobacco cessation programs (See Table 2). 
Discussion 
This study aimed to increase documentation of tobacco use screening in the primary care clinic 
after an education session on the USPSTF recommendation and Treating Tobacco Use and Dependence 
guideline was provided to all consented providers. Other aims of this study included increasing the 
provider’s documentation of counseling, prescribing of tobacco cessation medications, and initiating 
referrals to tobacco cessation programs. After comparing the pre-intervention data to the post-intervention 
data there were no statistically significant differences among any of the study’s variables. 
Overall, the adherence rate for documentation of tobacco use screening was 31.3% at both phases 
of the study. This suggests that only a third of the known smokers during these visits had documentation 
of being screened for tobacco use by the providers. The highest adherence rate in both phases of the study 
for tobacco screening documentation was found to be during annual visits. Annual visits were actually the 
least frequent type of visit encountered but had the highest adherence rate in documentation of tobacco 
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screening. According to the Center for Medicare and Medicaid Services (CMS), the annual “wellness” 
visit should include a personalized prevention plan to help prevent disease and disability based on the 
patient’s health and risk factors (CMS, 2016). There are many modifiable and non-modifiable risk factor 
screenings that are covered during this visit, including tobacco use cessation counseling. If these visits are 
focused mainly on prevention then it is conceivable that 100% of all annual visits seen should include the 
documentation of tobacco use screening and counseling. 
From 2005-2010 the CDC conducted a national survey that found that on average adults were 
screened for tobacco use during 65.6% of all ambulatory care visits. Of those who were identified as 
tobacco users, 20.7% received tobacco cessation counseling (CDC, 2014). The counseling rate of this 
study sample in both phases was higher than the national average. Although this clinic ranked higher than 
the national average on counseling, all known smokers, regardless of their readiness to quit, should be 
receiving counseling on the effects and consequences of continued tobacco use. When providers are 
consistent in providing tobacco cessation counseling and interventions at each visit, there is often a 
decrease in tobacco use as compared with no education provided (Laniado-Laborin, 2010). 
The Healthy People 2020 nationwide initiative goal for cigarette smoking is 12%, the most 
current data show that Kentucky is at 21.1% for cigarette smoking (ODPHP, 2014; Odani et al., 2018). 
This demonstrates that there is an opportunity for growth in primary care clinics within the state of 
Kentucky to improve tobacco use screenings and to provide evidenced-based counseling and 
interventions for successful tobacco cessation. 
Limitations and Implications for Future Research 
 There were several limitations identified in the design of this study. Although data were collected 
from a large primary care clinic, the study was limited to the specific Louisville, Kentucky region. A 
larger, multi-clinic, multi-regional comparison would help increase generalizability.  
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The intervention phase was limited to only two weeks for the providers and could have impacted 
how adequately they understood the material. Since the intervention consisted of a one-time education 
session and was initiated within a short period of time, implementation of the study objectives within the 
provider’s practice could have been difficult for them during their normal routine hours. As shown by the 
evidence in this study there was no single referral made for tobacco cessation in the post-intervention 
phase.  
Another limitation was the length and reach of this study. The education session and chart review 
were performed solely by the primary investigator. To see an impact and further comparison of the study 
objectives, this study could be replicated for at least one year and at multiple clinics. 
Further research should include identification of provider barriers to documentation of tobacco 
use screening, counseling, pharmacotherapy, and referrals. According to McBride et al., some perceived 
barriers to provider documentation include limited time allotted for each patient visit, lack of priority for 
and knowledge of the provider, and lack of teamwork within the office (1997).  
Conclusion 
 The continuous use of tobacco has serious consequences to our nation’s health. Tobacco use is 
the single most preventable cause of disease, disability and death in the United States. Primary care 
practices should place more emphasis on adopting a system-wide practice change on screening, 
counseling, medication and referral for all tobacco users and appropriately documenting those 
interventions. Tobacco use screening and cessation counseling is recognized as one of three most 
effective and efficacious preventive health actions that can be undertaken in a clinical setting (Agency for 
Healthcare Research and Quality [AHRQ], 2018). Meeting the recommended requirements for tobacco 
screening rates is a difficult task and should be confronted with a multidisciplinary approach within the 
practice. 
 
EFFECT OF PROVIDER EDUCATION PROGRAM ON TOBACCO USE 
12 
 
References 
 
Agency for Healthcare Research and Quality. (2018). Tobacco use counseling. Retrieved from 
http://www.ahrq.gov/professionals/prevention-chronic-care/healthier-
pregnancy/preventive/tobacco.html 
American Cancer Society. (2017). Health risks of smoking tobacco. Retrieved from 
https://www.cancer.org/cancer/cancer-causes/tobacco-and-cancer/health-risks-of-smoking-
tobacco.html 
Babb, S. (2017). Quitting smoking among adults—United States, 2000–2015. MMWR. Morbidity and 
Mortality Weekly Report, 65(52), 1457–1464. 
Centers for Disease Control and Prevention. (2014). Ambulatory health care data: NAMCS and 
NHAMCS Tables. Retrieved from https://www.cdc.gov/nchs/ahcd/web_tables.htm 
Centers for Disease Control and Prevention. (2017). Smoking and tobacco use. Second hand smoke 
(SHS) facts. Retrieved from 
https://www.cdc.gov/tobacco/data_statistics/fact_sheets/secondhand_smoke/general_facts/index.
htm 
Centers for Medicare & Medicaid Services (CMS). (2016). Annual Wellness Visit (AWV), 
Including Personalized Prevention Plan Services (PPPS). Medicare Learning Network. 
Retrieved from https://www.cms.gov/Outreach-and-Education/Medicare-Learning-
Network-MLN/MLNMattersArticles/downloads/MM7079.pdf 
Chaney, E. S., & Sheriff, S. (2012). Evidence-based treatments form smoking cessation. The Nurse 
Practitioner, 37(4), 24-31. 
Fiore, M.C., Jaén, C.R., Baker, T.B., et al. (2008). Treating tobacco use and dependence: 2008 Update. 
Clinical practice guideline. Rockville, MD: U.S. Department of Health and Human Services 
Public Health Service. Public Health Service, Agency for Healthcare Research and Quality. 
Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK63952/ 
EFFECT OF PROVIDER EDUCATION PROGRAM ON TOBACCO USE 
13 
 
Jamal, A., Homa, D. M., O'Connor, E., Babb, S. D., Caraballo, R. S., Singh, T., ... & King, B. A. (2015). 
Current cigarette smoking among adults—United States, 2005–2014. MMWR Morbidity & 
Mortality Weekly Report, 64(44), 1233-1240. 
Jamal, A., Dube, S. R., & King, B. A. (2015). Tobacco use screening and counseling during hospital 
outpatient visits among US adults, 2005-2010. Preventing Chronic Disease. (12). E132. 
doi:10.5888/pcd12.140529 
Jamal A., Phillips E., Gentzke A. S., Homa, M. D., Babb, D. S., King, B. A., Neff, J. L. (2018).  Current 
cigarette smoking among adults — United States, 2016. MMWR Morbidity & Mortality Weekly 
Report, 67(2), 53–59. doi: http://dx.doi.org/10.15585/mmwr.mm6702a1 
McBride, E. P., Plane, B. M., Underbakke, G., Brown, L. R., Leif I., Solberg, I L. (1997). Smoking 
screening and management in primary care practices. Archives of Family Medicine.6(2).165-172. 
Laniado-Laborin, R., (2010). Smoking cessation intervention: An evidence-based approach. Post 
Graduate Medicine, 122(2), 74-82. 
Odani, S., Armour, B. S., Graffunder, C. M., Willis, G., Hartman, A. M., Agaku, I. T. (2018). State-
specific prevalence of tobacco product use among adults - United States, 2014-2015. MMWR 
Morbidity & Mortality Weekly Report, 67(3), 97-102. doi: 10.15585/mmwr.mm6703a3 
Office of Disease Prevention and Health Promotion (ODPHP). 2014. Tobacco use. Retrieved from 
https://www.healthypeople.gov/2020/topics-objectives/topic/tobacco-use/objectives 
United States Department of Health and Human Services (DHHS). (2014). The health consequences of 
smoking-50 years of progress: A report of the surgeon general. Atlanta: US. Department of 
Health and Human Services, Centers for Disease Control and Prevention, National Center for 
Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. Retrieved 
from https://www.surgeongeneral.gov/library/reports/50-years-of-progress/full-report.pdf 
United States Preventive Services Task Force. (September, 2015. Final update summary: Tobacco 
smoking cessation in adults, including pregnant women: Behavioral and pharmacotherapy 
EFFECT OF PROVIDER EDUCATION PROGRAM ON TOBACCO USE 
14 
 
interventions. Retrieved from 
https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/tobacco-
use-in-adults-and-pregnant-women-counseling-and-interventions1 
World Health Organization (WHO), 2017. Global health observatory data. Prevalence of tobacco smoking. 
Retrieved from http://www.who.int/gho/tobacco/use/en/  
EFFECT OF PROVIDER EDUCATION PROGRAM ON TOBACCO USE 
15 
 
Table 1. Demographic characteristics of the study sample  
 
 Pre-implementation 
(N=96) n (%)  
Post-implementation 
(N=99) 
n (%)  
 
P 
Age 
18-40 
41-60 
61 and above 
 
26 (27.1) 
46 (47.9) 
24 (25.0) 
 
37 (37.4) 
41 (41.4) 
21 (21.2) 
 
 
0.307 
Gender 
   Male 
   Female 
 
41 (42.7) 
55 (57.3) 
 
36 (36.4) 
63 (63.6) 
 
 
 
0.365 
Race/Ethnicity 
Caucasian 
African American 
Hispanic  
Other 
 
77 (80.2) 
11 (11.5) 
5 (5.2) 
3 (3.1) 
 
73 (74.5) 
20 (20.4) 
1 (1.0) 
4 (4.1) 
 
 
 
0.138 
Health Insurance 
Commercial 
Medicaid 
Medicare 
No Insurance 
 
33 (34.4) 
33 (34.4) 
30 (31.2) 
0 (0) 
 
38 (38.4) 
35 (35.4) 
24 (24.2) 
2 (2) 
 
 
 
0.375 
Type of Visit 
Annual 
Episodic 
Follow-up 
 
14 (14.6) 
45 (46.9) 
37 (38.5) 
 
20 (20.2) 
47 (47.5) 
32 (32.3) 
 
 
0.492 
Type of Provider  
Nurse Practitioner 
Physician 
 
57 (59.4) 
39 (40.6) 
 
 
47 (47.5) 
52 (52.5) 
 
 
 
0.096 
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Table 2. Comparison of documentation, counseling, medication and referral for smoking cessation before 
and after an education intervention.  
 
 
 Pre-Education (n=96) 
n (%) 
Post-Education (n=99) 
n (%) 
P 
Documentatation of 
tobacco use: 
Yes 
No 
 
 
30 (31.3) 
66 (68.8) 
 
 
31 (31.3) 
68 (68.7) 
 
 
0.992 
Counseling 
Yes 
No 
 
25 (26.0) 
71 (74.0) 
 
31 (31.3) 
68 (68.7) 
 
0.416 
Medication 
Yes 
No 
 
10 (10.4) 
86 (89.6) 
 
12 (12.1) 
87 (87.9) 
 
0.707 
Referral 
Yes 
No 
 
1 (1.0) 
95 (99.0) 
 
 
0 (0) 
99 (100) 
 
0.309 
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Figure 1. Adherence to tobacco screening based on type of visit 
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Figure 2. Number of FDA-approved tobacco cessation medications prescribed 
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Appendix A 
Educational Handout and Tip Sheets for EMR Documentation 
 
Education to Primary Care Clinic, Louisville, Kentucky. 
Sunita Gurung, DNP-student 2018, University of Kentucky 
 
 
 
 
Project Aim:  
Decrease the rate of smoking in the NCMA patient group 
Goal 
o Increase provider knowledge on current smoking guidelines. 
o Screen patient for smoking status 
o Discuss smoking status and readiness to quit 
o Increase patient knowledge on the effects of smoking and different ways to quit. 
o Provide patient the tobacco cessation resources. 
Background 
o One of the most preventable reason for morbidity and mortality in the United States. 
o 1.1 billion people smoked tobacco in 2015 and killing over seven million people around the 
world. 
o Twenty percent death are caused by cigarette smoking. 
o More than 300 billion dollars cost in healthcare expenditure 
o 480,000 premature deaths in the United States 
o Tobacco use in Kentucky 29.6% 
o An estimated 70% of smokers have expressed desired to quit. 
 
Health risk related to smoking: 
o COPD 
o Stroke 
o Lung Cancer 
o Peripheral Vascular Disease 
o Diabetes 
o Cancer of Bladder, Cervix, Colon, Rectum, Esophagus, Liver, Pancreas, Stomach. 
o Fertility, pregnancy, fetal complication. 
o Infection 
o Dental, vision hearing problems. 
 
Tobacco Cessation Strategies 
The United States Preventative Task Force (USPSTF) had issued a Grade A recommendation that 
healthcare provider should screen patients on tobacco use and provide tobacco cessation interventions to 
those who use tobacco products (USPSTF, 2015).  Healthcare provider can utilize the “5-A” framework 
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for the counseling strategy because this strategy gives the healthcare provider to assess the patient 
smoking history, number of packs of cigarette smoking and readiness to quit (USPSTF, 2014): 
1)      Ask about the tobacco use. 
2)      Advice to quit through clear personalized messages. 
3)      Assess willingness to quit. 
4)      Assist to quit. 
5)      Arrange follow- up and support. 
The USPSTF, 2015 also recommend counseling directly with patients for longer or multiple 
sessions. Telephone counseling (1-800-QUIT-NOW) “quit lines” also improve the cessation rates. Quit 
are free service and is available 24/7. Patient can speak with trained person. Patient can contact at any 
point during the process of quit time or after quitting.                                                 
Pharmacotherapy: Combination of counseling and medication are more effective than either alone. FDA 
approved nicotine replacement therapy includes, sustained release bupropion and Varenicline. 
The seven first line medication (5 nicotine and 2 non-nicotine) reliably increase long-term smoking 
abstinence rates. Bupropion SR, Nicotine gum, Nicotine inhaler, Nicotine lozenge. Nicotine nasal spray, 
Nicotine patch, Varenicline.  
Implementation/Strategies: Set a quit date. Inform family, friends, coworkers about quit date. Inform 
patient in Nicotine withdrawal for couple week. Remove all the tobacco from the environment. 
U.S Preventative Services Task Forces: 
Tobacco Smoking Cessation in Adults, Including Pregnant Women: Behavioral and Pharmacotherapy 
Interventions 
Population Nonpregnant adults 
age ≥18 y 
Pregnant women age 
≥18 y 
Pregnant women age 
≥18 y 
All adults age ≥18 y 
Recommendation Provide 
pharmacotherapy and 
behavioral 
interventions for 
cessation. 
Grade: A 
Provide behavioral 
interventions for 
cessation. 
Grade: A 
Pharmacotherapy 
interventions: No 
recommendation. 
Grade: I statement 
ENDS: No 
recommendation. 
Grade: I statement 
Assessment The 5 A's framework is a useful strategy for engaging patients in smoking cessation discussions. 
The “5 A's” include: 1) Asking every patient about tobacco use, 2) Advising them to quit, 3) 
Assessing their willingness to quit, 4) Assisting them with quitting, and 5) Arranging follow-up. 
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Behavioral 
Counseling 
Interventions 
Behavioral 
interventions alone 
(in-person behavioral 
support and 
counseling, telephone 
counseling, and self-
help materials) or 
combined with 
pharmacotherapy 
substantially improve 
achievement of 
tobacco cessation. 
Behavioral 
interventions 
substantially improve 
achievement of 
tobacco smoking 
abstinence, increase 
infant birthweight, 
and reduce risk for 
preterm birth. 
    
Pharmacotherapy 
Interventions 
Pharmacotherapy 
interventions, 
including NRT, 
bupropion SR, and 
varenicline—with or 
without behavioral 
counseling 
interventions—
substantially improve 
achievement of 
tobacco cessation. 
  There is inadequate or 
no evidence on the 
benefits of NRT, 
bupropion SR, or 
varenicline to achieve 
tobacco cessation in 
pregnant women or 
improve perinatal 
outcomes in infants. 
There is inadequate 
evidence on the 
benefit of ENDS to 
achieve tobacco 
cessation in adults or 
improve perinatal 
outcomes in infants. 
Balance of Benefits 
and Harms 
The USPSTF 
concludes with high 
certainty that the net 
benefit of behavioral 
interventions and 
FDA-approved 
pharmacotherapy for 
tobacco cessation, 
alone or in 
combination, is 
substantial. 
The USPSTF 
concludes with high 
certainty that the net 
benefit of behavioral 
interventions for 
tobacco cessation on 
perinatal outcomes 
and smoking 
abstinence is 
substantial. 
The USPSTF 
concludes that the 
evidence on 
pharmacotherapy 
interventions for 
tobacco cessation is 
insufficient because 
of a lack of studies, 
and the balance of 
benefits and harms 
cannot be determined. 
The USPSTF 
concludes that the 
evidence on the use of 
ENDS for tobacco 
cessation is 
insufficient, and the 
balance of benefits 
and harms cannot be 
determined 
Other Relevant 
USPSTF 
Recommendations 
The USPSTF recommends that primary care clinicians provide interventions, including 
education or brief counseling, to prevent the initiation of tobacco use in school-aged children and 
adolescents. This recommendation is available at http://www.uspreventiveservicestaskforce.org. 
For a summary of the evidence systematically reviewed in making these recommendations, the full recommendation 
statement, and supporting documents, please go to http://www.uspreventiveservicestaskforce.org. 
Disclaimer: Recommendations made by the USPSTF are independent of the U.S. government. They should not be 
construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of 
Health and Human Services. 
Current as of: September 2015 
 
Internet Citation: Clinical Summary: Tobacco Smoking Cessation in Adults, Including Pregnant Women: 
Behavioral and Pharmacotherapy Interventions. U.S. Preventive Services Task Force. September 2015. 
https://www.uspreventiveservicestaskforce.org/Page/Document/ClinicalSummaryFinal/tobacco-use-in-adults-and-
pregnant-women-counseling-and-interventions1 
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Fiore MC, Jaén CR, Baker TB, et al. (2008). US Department of Health and Human Services, “Treating 
Tobacco Use and Dependence: 2008 Update”. Ten Key Guideline Recommendations: 
The overarching goal of these recommendations is that clinicians strongly recommend the use of 
effective tobacco dependence counseling and medication treatments to their patients who use 
tobacco, and that health systems, insurers, and purchasers assist clinicians in making such 
effective treatments available. 
 
1.Tobacco dependence is a chronic disease that often requires repeated intervention and multiple 
attempts to quit. Effective treatments exist, however, that can significantly increase rates of long-
term abstinence. 
 
2.It is essential that clinicians and health care delivery systems consistently identify and 
document tobacco use status and treat every tobacco user seen in a health care setting. 
 
3.Tobacco dependence treatments are effective across a broad range of populations. Clinicians 
should encourage every patient willing to make a quit attempt to use the counseling treatments 
and medications recommended in this Guideline. 
 
4.Brief tobacco dependence treatment is effective. Clinicians should offer every patient who uses 
tobacco at least the brief treatments shown to be effective in this Guideline. 
 
5.Individual, group, and telephone counseling are effective, and their effectiveness increases 
with treatment intensity. Two components of counseling are especially effective, and clinicians 
should use these when counseling patients making a quit attempt: Practical counseling 
(problemsolving/skills training) Social support delivered as part of treatment. 
 
6.Numerous effective medications are available for tobacco dependence, and clinicians should 
encourage their use by all patients attempting to quit smoking—except when medically 
contraindicated or with specific populations for which there is insufficient evidence of 
effectiveness (i.e., pregnant women, smokeless tobacco users, light smokers, and adolescents). 
Seven first-line medications (5 nicotine and 2 non-nicotine) reliably increase long-term smoking 
abstinence rates: 
Bupropion SR 
Nicotine gum 
Nicotine inhaler 
Nicotine lozenge 
Nicotine nasal spray 
Nicotine patch 
Varenicline 
Clinicians also should consider the use of certain combinations of medications identified as 
effective in this Guideline. 
 
7.Counseling and medication are effective when used by themselves for treating tobacco 
dependence. The combination of counseling and medication, however, is more effective than 
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either alone. Thus, clinicians should encourage all individuals making a quit attempt to use both 
counseling and medication. 
 
8.Telephone quitline counseling is effective with diverse populations and has broad reach. 
Therefore, both clinicians and health care delivery systems should ensure patient access to 
quitlines and promote quitline use. 
 
9.If a tobacco user currently is unwilling to make a quit attempt, clinicians should use the 
motivational treatments shown in this Guideline to be effective in increasing future quit attempts. 
 
10. Tobacco dependence treatments are both clinically effective and highly cost-effective relative 
to interventions for other clinical disorders. Providing coverage for these treatments increases 
quit rates. Insurers and purchasers should ensure that all insurance plans include the counseling 
and medication identified as effective in this Guideline as covered benefits. 
 
A comparison of the findings of the updated Guideline with the 2000 Guideline reveals the 
considerable progress made in tobacco research over the brief period separating these two 
publications. Tobacco dependence increasingly is recognized as a chronic disease, one that 
typically requires ongoing assessment and repeated intervention. In addition, the updated 
Guideline offers the clinician many more effective treatments strategies than were identified in 
the original Guideline. There now are seven different first-line effective agents in the smoking 
cessation pharmacopoeia, allowing the clinician and patient many different medication options. 
In addition, recent evidence provides even stronger support for counseling (both when used alone 
and with other treatments) as an effective tobacco cessation strategy; counseling adds to the 
effectiveness of tobacco cessation medications, quitline counseling is an effective intervention 
with a broad reach, and counseling increases tobacco cessation among adolescent smokers. 
Finally, there is increasing evidence that the success of any tobacco dependence treatment 
strategy cannot be divorced from the health care system in which it is embedded. The updated 
Guideline contains new evidence that health care policies significantly affect the likelihood that 
smokers will receive effective tobacco dependence treatment and successfully stop tobacco use. 
For instance, making tobacco dependence treatment a covered benefit of insurance plans 
increases the likelihood that a tobacco user will receive treatment and quit successfully. Data 
strongly indicate that effective tobacco interventions require coordinated interventions. Just as 
the clinician must intervene with his or her patient, so must the health care administrator, insurer, 
and purchaser foster and support tobacco intervention as an integral element of health care 
delivery. Health care administrators and insurers should ensure that clinicians have the training 
and support to deliver consistent, effective intervention to tobacco users. 
One important conclusion of this Guideline update is that the most effective way to move 
clinicians to intervene is to provide them with information regarding multiple effective treatment 
options and to ensure that they have ample institutional support to use these options. Joint actions 
by clinicians, administrators, insurers, and purchasers can encourage a culture of health care in 
which failure to intervene with a tobacco user is inconsistent with standards of care.  
 
Smoking and Tobacco Use Cessation Counseling Visit Documentation for Billing. 
Excludes for group 
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• 99406- Intermediate, minimum of 3 min, up to 10 minutes  
• 99407- Intensive, (greater than) 10 minutes 
• G0436- For Medicare; minimum of 3 min, up to 10 min (this will occur on the backend) 
• G0437- For Medicare; (greater than) 10 min (this will occur on the backend) 
Qualifications of charge for patients:  
1.) Who use tobacco, regardless of whether they have signs/symptoms of tobacco-related disease;  
2.) Who are competent and alert at the time that counseling is provided; and,  
3.) Whose counseling is furnished by a qualified physician or other Medicare-recognized 
practitioner 
Documentation should include:  
• A diagnosis to support billing of the code (Ex. Tobacco use/Abuse - Z72.0) 
• The amount of the patients tobacco use 
• The History of use (current/dependent/past) 
• The amount of time spent on tobacco cessation counseling 
• The context in which it was provided; suggested actions and motivational counseling 
• Specific validated interventions of assessing readiness for change and barriers to change 
• Advise a change in behavior 
• Arranging for services and follow-up 
• Up to 4 cessation counseling sessions ( 1 attempt =up to 4 sessions)  
• Two cessation counseling attempts (or up to 8 cessation counseling sessions) are allowed every 
12 months (for Medicare, commercial payers vary) 
Referral to Smoking Cessation Program 
This tip sheet describes the process of submitting a referral order to the Smoking Cessation Program. 
Provider Workflow 
1. Within an Office Visit, Orders Only or Telephone encounter, select the Meds & Orders 
section.  
2. Select the  New Order button to open the office-level preference list.   
  
3. If you have an established user preference list, de-select the “Only Favorites” checkbox. 
 
4. Expand the Referrals preference list on the left, and select Referrals. 
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5. Select the Smoking Cessation Program order.  
 
6. Click Accept.  
7. The Smoking Cessation Program is now listed under the Unsigned Orders section of 
Medications & Orders. Select the summary sentence to open the Order Composer.  
 
8. The Smoking Cessation Program order’s “To dept spec” field defaults to ‘Prevent and 
Wellness’. 
 
You Can Also... 
 Search for the Smoking Cessation Program order.  
1. In the Medications & Orders section, click the New Order button.  
 
2. The Preference List Browser opens on the Browse tab.  
 
3. Search for the Smoking Cessation Program in the search box.  
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